Delivery Order SPE2DB22D3004-SPE2DB25FPH19
Award Date
1/29/25
Potential Completion Date
2/20/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,343.59, is a Firm Fixed Price Delivery Order for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML". The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.59 Firm Fixed Price Delivery Order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award, valued at $2,343.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through December 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $2,343.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a period of performance through January 7, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. In addition to this specific award, AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,374.36, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a ceiling value of $2,343.59. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,343.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with an ultimate completion date of February 27, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The $4,530.60 firm-fixed-price delivery order contract has a completion date of November 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a wide range of medical products,...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical commodities to the U.S. military. The $4,530.60 delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance ending on September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,326.45 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, which will be delivered by November 27, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...